Hand–Foot–Mouth Disease

A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Epidemiology of Infectious Diseases".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 1722

Special Issue Editor

Special Issue Information

Dear Colleagues,

Hand–foot–mouth disease (HFMD) is a common infectious disease caused by a variety of enteroviruses.   Enterovirus 71 (EV71) and Coxsackie virus A 16 (CA-16) are the major etiologic agents of HFMD and herpangina. Children under five years are particularly susceptible to contracting HFMD. EV71 was first isolated from a child with encephalitis in California in 1969. Since that time, several epidemics of EV71 have been reported. The clinical spectrum of HFMD presents with a wide range of clinical manifestations, including cutaneous, visceral, and neurological disorders. In recent years, HFMD has been known to cause several large-scale outbreaks of severe complications in children involving the central nervous system (CNS). Although present in most countries, most outbreaks of the disease have been found in the Asia-Pacific region; the reasons for this phenomenon are unclear. Because of the potential for causing severe neurologic disease by this virus, we need to understand the epidemiology, pathogenesis, transmission mechanism, diagnosis, treatment, and prevention of HFMD. 

Prof. Dr. Kow-Tong Chen
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • hand–foot–mouth disease
  • Coxsackie virus
  • epidemiology
  • pathogenesis
  • prevention

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

20 pages, 5838 KiB  
Article
Leucoverdazyls as Novel Potent Inhibitors of Enterovirus Replication
by Alexandrina S. Volobueva, Tatyana G. Fedorchenko, Galina N. Lipunova, Marina S. Valova, Valeriya A. Sbarzaglia, Anna S. Gladkikh, Olga I. Kanaeva, Natalia A. Tolstykh, Andrey N. Gorshkov and Vladimir V. Zarubaev
Pathogens 2024, 13(5), 410; https://doi.org/10.3390/pathogens13050410 - 15 May 2024
Viewed by 1151
Abstract
Enteroviruses (EV) are important pathogens causing human disease with various clinical manifestations. To date, treatment of enteroviral infections is mainly supportive since no vaccination or antiviral drugs are approved for their prevention or treatment. Here, we describe the antiviral properties and mechanisms of [...] Read more.
Enteroviruses (EV) are important pathogens causing human disease with various clinical manifestations. To date, treatment of enteroviral infections is mainly supportive since no vaccination or antiviral drugs are approved for their prevention or treatment. Here, we describe the antiviral properties and mechanisms of action of leucoverdazyls—novel heterocyclic compounds with antioxidant potential. The lead compound, 1a, demonstrated low cytotoxicity along with high antioxidant and virus-inhibiting activity. A viral strain resistant to 1a was selected, and the development of resistance was shown to be accompanied by mutation of virus-specific non-structural protein 2C. This resistant virus had lower fitness when grown in cell culture. Taken together, our results demonstrate high antiviral potential of leucoverdazyls as novel inhibitors of enterovirus replication and support previous evidence of an important role of 2C proteins in EV replication. Full article
(This article belongs to the Special Issue Hand–Foot–Mouth Disease)
Show Figures

Figure 1

Back to TopTop